Difficulty: Medium
Average Score: 87%
Practice
Which of the following adrenoreceptor antagonists crosses the blood-brain barrier?
Correct answer
A
Rationale
In the context of lifespan pharmacology, understanding the ability of medications to cross the blood-brain barrier is crucial as it impacts their efficacy in central nervous system-related conditions. In this question, the correct answer is A) Propranolol.
Propranolol is a lipophilic non-selective beta-blocker that can readily cross the blood-brain barrier due to its lipophilicity. Once in the brain, it can exert its effects centrally, making it useful in conditions like migraines, anxiety, and essential tremors.
On the other hand, options B) Atenolol, C) Acebutolol, and D) Nadolol are hydrophilic beta-blockers that do not easily cross the blood-brain barrier. Their inability to penetrate the central nervous system limits their effectiveness in conditions requiring central action.
Educationally, this question highlights the importance of drug properties in determining their ability to reach target sites within the body. Understanding the pharmacokinetics of medications helps healthcare professionals make informed decisions when selecting treatments for patients across the lifespan.
Propranolol is a lipophilic non-selective beta-blocker that can readily cross the blood-brain barrier due to its lipophilicity. Once in the brain, it can exert its effects centrally, making it useful in conditions like migraines, anxiety, and essential tremors.
On the other hand, options B) Atenolol, C) Acebutolol, and D) Nadolol are hydrophilic beta-blockers that do not easily cross the blood-brain barrier. Their inability to penetrate the central nervous system limits their effectiveness in conditions requiring central action.
Educationally, this question highlights the importance of drug properties in determining their ability to reach target sites within the body. Understanding the pharmacokinetics of medications helps healthcare professionals make informed decisions when selecting treatments for patients across the lifespan.